Details for: CL0000051

Cell ID: CL0000051

Cell Name: common lymphoid progenitor

Description: CLP are CD7-positive, CD10-positive, CD19-negative, CD34-positive, CD45RA-positive, CD79a-negative, CD127-positive, AA4.1-positive, RAG-negative, Sca-1-low, sIgM-negative, sIgD-negative, TdT-negative, Vpre-B-negative, and pre-BCR-negative. Expression of transcription factors include E2A-positive, EBF-positive, Ikaros-negative, PU.1-negative, and Pax5-negative.

Synonyms: committed lymphopoietic stem cell, common lymphocyte precursor, common lymphocyte progenitor, common lymphoid precursor, early lymphocyte progenitor, lymphoid stem cell, lymphopoietic stem cell, CLP, ELP

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for common lymphoid progenitor within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for common lymphoid progenitor. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for common lymphoid progenitor. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for common lymphoid progenitor. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  common lymphoid progenitor (CL0000051)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [common lymphoid progenitor](/details-cell/CL0000051) (CLP) is a hematopoietic stem cell derivative committed to the lymphoid lineage, capable of differentiating into B cells, T cells, and natural killer (NK) cells. The provided gene significance data, from an **Overall** biological context, underscores the CLP's identity as a highly active and proliferative progenitor. The top-ranking genes are not lineage-specific markers but rather essential components of fundamental cellular machinery. This includes proteins involved in chromatin architecture ([HMGB1](/details-gene/3146)), ribosome biogenesis ([NPM1](/details-gene/4869)), and a striking number of factors for RNA processing and translation ([HNRNPA2B1](/details-gene/3181), [HNRNPC](/details-gene/3183)). This molecular signature is consistent with a cell maintaining a state of developmental plasticity while being primed for rapid protein synthesis, cell division, and differentiation upon receiving appropriate signals from the bone marrow microenvironment. ## Key Characteristics and Function The gene expression profile of the [common lymphoid progenitor](/details-cell/CL0000051) highlights its role as a dynamic and metabolically active cell factory, poised for lineage commitment. The top markers, identified by their high expression specificity (`csi_z`), can be organized into several key functional clusters: * **Chromatin Organization and Transcriptional Plasticity:** The highest-ranked marker, [HMGB1](/details-gene/3146), is a non-histone chromosomal protein that modulates chromatin structure and DNA bending, which is critical for regulating transcription ([Link](https://pubmed.ncbi.nlm.nih.gov/2922262/)). Its prominence, along with histone variants like [H3 3B](/details-gene/3021) and [H3 3A](/details-gene/3020), suggests that the CLP maintains an open and accessible chromatin landscape. This plasticity is essential for a multipotent progenitor that must be ready to activate diverse, lineage-specific gene expression programs. * **RNA Processing and Splicing Machinery:** A remarkably large number of the top markers are heterogeneous nuclear ribonucleoproteins (hnRNPs) and RNA-binding proteins, such as [HNRNPA2B1](/details-gene/3181), [HNRNPC](/details-gene/3183), [HNRNPDL](/details-gene/9987), [HNRNPA3](/details-gene/220988), [RBM39](/details-gene/9584), and [DDX5](/details-gene/1655). This strong enrichment indicates that post-transcriptional regulation, including alternative mRNA splicing, is a central biological process in CLPs. This machinery likely plays a crucial role in generating the complex proteome required for proliferation and the initial steps of differentiation down distinct lymphoid pathways. * **Ribosome Biogenesis and Protein Synthesis:** Key genes involved in building and operating the translational machinery are highly significant. [NPM1](/details-gene/4869) is critical for ribosome assembly and transport ([Link](https://pubmed.ncbi.nlm.nih.gov/2713355/)), while [EEF1B2](/details-gene/1933) is a core component of the translation elongation machinery. The presence of [SRP14](/details-gene/6727), part of the signal recognition particle, further supports the notion of high-volume protein synthesis, preparing the cell for rapid growth and division. * **High Metabolic Activity:** The specific expression of genes involved in core metabolic pathways, such as glycolysis ([GAPDH](/details-gene/2597)) and oxidative phosphorylation ([ATP5MC2](/details-gene/517), [COX4I1](/details-gene/1327), [COX1](/details-gene/4512)), points to the high energy demands of this progenitor cell. This metabolic readiness is necessary to fuel the anabolic processes of proliferation and differentiation. **Conversely**, the anti-markers profile confirms the cell's identity by exclusion. The low significance of the myeloid-specific enzyme myeloperoxidase ([MPO](/details-gene/4353)) and the granulocyte colony-stimulating factor receptor ([CSF3R](/details-gene/1441)) reinforces the CLP's commitment away from the myeloid lineage. Furthermore, low levels of receptors associated with more mature lymphocyte functions, like [TNFRSF18](/details-gene/8784) (GITR), are consistent with its progenitor status. ## Clinical Significance and Contextual Roles While this analysis is based on a single **Overall** context, the specific gene signature of CLPs has significant clinical implications, particularly in hematology and oncology. The genes that define this cell type are frequently dysregulated in hematological malignancies. The high specificity of [NPM1](/details-gene/4869) is particularly noteworthy, as mutations in this gene are a hallmark of acute myeloid leukemia (AML) and influence disease prognosis. While the data here relates to a lymphoid progenitor, the critical role of [NPM1](/details-gene/4869) in maintaining hematopoietic cell function suggests its dysregulation could also be a key event in the pathogenesis of acute lymphoblastic leukemias (ALL) originating from this cellular stage. Similarly, [HMGB1](/details-gene/3146), the top marker, is recognized as a damage-associated molecular pattern (DAMP) or alarmin. When released from cells, it can promote inflammation and has been implicated in the progression of various cancers ([Link](https://pubmed.ncbi.nlm.nih.gov/9036861/)). The exceptionally high expression of [HMGB1](/details-gene/3146) in CLPs suggests that under conditions of stress or high cell turnover in the bone marrow, these progenitors could be a significant source of this pro-inflammatory and potentially pro-tumorigenic molecule, thereby shaping the bone marrow microenvironment. The extensive machinery for RNA splicing, defined by the high significance of multiple hnRNP family members, represents another area of clinical relevance. Aberrant splicing is a known driver of cancer, and the specific splicing factors that characterize CLPs could represent therapeutic vulnerabilities. Targeting the splicing process in leukemias derived from CLPs may offer a potential avenue for novel treatments. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The profound enrichment of RNA-binding proteins and splicing factors (e.g., [HNRNPA2B1](/details-gene/3181), [HNRNPC](/details-gene/3183), [RBM39](/details-gene/9584)) suggests that alternative splicing serves as a primary regulatory hub for controlling lymphoid lineage commitment in CLPs. This post-transcriptional control layer may integrate upstream signals to generate specific protein isoforms that are the ultimate drivers of differentiation towards B, T, or NK cell fates. * **Surprising Findings:** The dominance of these general RNA processing factors over classical lineage-determining transcription factors in the top marker list is unexpected. This suggests that at this specific developmental checkpoint, the regulation of which mRNA isoforms are produced may be a more specific and critical determinant of cell identity and fate than the simple act of gene transcription itself. * **Testable Questions:** Does single-cell RNA sequencing of CLPs and their immediate progeny reveal distinct, lineage-associated alternative splicing patterns that precede changes in whole-gene transcription levels? Furthermore, does the conditional knockout of a top-ranked splicing factor like [RBM39](/details-gene/9584) in hematopoietic progenitors lead to a block in lymphoid development or a skewing of differentiation towards a particular lineage? 2. **Hypothesis:** The top-ranked gene, [HMGB1](/details-gene/3146), functions as a critical dual-role regulator in CLP biology. Intracellularly, its primary function is to maintain the chromatin in a plastic, 'poised' state necessary for multipotency. Extracellularly, following release from apoptotic or stressed CLPs, it acts as a key alarmin within the bone marrow niche, signaling to hematopoietic stem cells and other progenitors to modulate their proliferation and differentiation in response to stress or infection. * **Surprising Findings:** Although [HMGB1](/details-gene/3146) is considered a housekeeping gene, its rank as the top marker for expression *specificity* (`csi_z`) is highly unusual. This implies its expression in CLPs is quantitatively distinct and more tightly regulated than in most other cell types, pointing towards a specialized, non-canonical role beyond its general function in chromatin maintenance. * **Testable Questions:** Can the addition of recombinant [HMGB1](/details-gene/3146) to in vitro cultures of hematopoietic stem and progenitor cells alter the output or differentiation kinetics of CLPs? Does a conditional knockout of [HMGB1](/details-gene/3146) in the hematopoietic system impair the recovery of the lymphoid compartment following myelosuppressive injury?